key: cord-0745971-yn8t2k5z authors: Kilic, Talat; Kilic, Sebnem; Berber, Nurcan Kırıcı; Gunduz, Ayten; Ersoy, Yasemin title: Investigation of SARS‐CoV‐2 RNA in milk produced by women with COVID‐19 and follow‐up of their infants: A preliminary study date: 2021-04-17 journal: Int J Clin Pract DOI: 10.1111/ijcp.14175 sha: 0c8a9ced68169437df061cfdec7d3020c6ea3635 doc_id: 745971 cord_uid: yn8t2k5z OBJECTIVES: Studies have shown that severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is primarily transmitted from person to person via airborne droplets. It is unclear whether it can be shed into human milk and transmitted to a child via breastfeeding. We investigated the presence of SARS‐CoV‐2 RNA in human milk samples of 15 mothers with coronavirus disease 19 (COVID‐19) and in the throat swab samples of their infants. METHODS: This is a prospective observational study in which breast milk samples were collected from 15 mothers with COVID‐19. The presence of SARS‐CoV‐2 RNA in the whole human milk samples of the patients was investigated using RT‐qPCR. All of the infants underwent a clinical follow‐up during their 14‐day isolation and their throat swab samples were tested for SARS‐CoV‐2 RNA. RESULTS: Of 15 mothers with COVID‐19, SARS‐CoV‐2 RNA was detected in milk samples from 4 mothers. The throat swab samples from these mothers’ infants were found to be positive for SARS‐CoV‐2 RNA. Three of the four mothers were breastfeeding. In addition, during the 14‐day isolation, all but three of the mothers breastfed their infants. Of the 12 breastfed infants, while the test for SARS‐CoV‐2 RNA in throat swab samples was negative in 6 of the infants, the other 6 infants, who had mild COVID‐19 symptoms, tested positive for SARS‐CoV‐2 RNA. Clinical outcomes of all mothers and infants were uneventful. CONCLUSION: To our knowledge, this is the first case series with the largest number of cases with SARS‐CoV‐2 RNA positivity in human milk samples of mothers with COVID‐19. However, we believe that the benefits of breastfeeding may outweigh the risk of SARS‐CoV‐2 infection in infants. All cases of COVID-19 were diagnosed by RT-qPCR assays of throat swabs, in accordance with updated guidance. 3 SARS-CoV-2 RNA was investigated in throat samples of infants within 2 days after PCR positivity was detected in throat samples of all but one (case 15) mother. Chest computed tomography (CT) scans were performed in patients with appropriate indications. We collected clinical records, breastfeeding history and laboratory and radiological findings related to SARS-CoV-2 of 15 mothers and their infants during their hospital stay and during the 14-day isolation after discharge. Milk collection was performed with a dedicated breast pump in 9 of the mothers and with manual expression in 6 of the mothers. All of the mothers were advised to follow strict hygienic rules according to international recommendations. 3 During expression, the mothers wore a surgical mask, and they cleaned their hands with water and soap for at least 15-20 seconds prior to expression. Iodine was used to disinfect the breasts of all patients before milk collection. Samples were stored in sterile containers. Because case 1 had nipple retraction and adhesions, milk sample collection from case 1 using a manual pump required immense effort by the nurse. The nurse wore personal protective equipment to help prevent contamination. Generally, human milk samples were taken within 2 days after the mothers' symptoms began. All milk samples were examined for the presence of SARS-CoV-2 RNA on the day of sample collection; the milk was not frozen before the analysis. Seven mothers (cases 1, 2, 4, 9, 12, 13 and 15) expressed their milk in the hospital ward where they were hospitalised, while the others expressed it at home. In mothers whose first milk sample had negative PCR results, a second milk sample was taken 24 hours later. Thus, a total of 26 milk samples were obtained from 15 mothers. On the day each sample was collected, the whole human milk samples were examined for the presence of SARS-CoV-2 RNA at the microbiology laboratory of our center by a team of experts. The presence of SARS-CoV-2 RNA in the patients' milk samples was investigated What's new SARS-CoV-2 RNA was detected in human milk samples from 4 of 15 mothers with COVID-19. To the best of our knowledge, this is the first case series with the largest number of cases with SARS-CoV-2 RNA positivity in human milk samples of mothers with COVID-19. These findings suggest that SARS-CoV-2 can be shed into human milk. In addition, since one of the four mothers with a milk sample positive for SARS-CoV-2 RNA was not breastfeeding, the risk of transmission from the infant to the mother's milk was ruled out. Case 13 Case 14 Age (year) Mother-infant contact Immediate separation Table 1 . The main clinical features of the patients in the case series and the results of the analysis of the presence of SARS-CoV-2 RNA in milk and throat samples are shown in Cycle threshold values; c Human milk collection was performed with manual expression. | 5 of 7 This mother was a 31-year-old woman at 33 weeks of gestation. She had a history of gestational diabetes and had hypothyroid- was detected in the throat swabs of the twin newborns immediately after delivery. The mother and her newborns were declared healthy and discharged on the 10th and 12th day of hospitalisation, respectively. Both the mother and her twin newborns were found to be negative for SARS-CoV-2 RNA at two consecutive throat swabs before being discharged. In this prospective study, we showed that human milk samples from In a study by Liu et al, 9 10 milk samples were obtained from mothers after their first lactation. These samples were tested for the presence of SARS-CoV-2 RNA using the RT-qPCR test, revealing negative results. 9 In another study that enrolled 18 women who had In a previous case series, although SARS-CoV-2 RNA was detected in one human milk sample from a mother with COVID-19, the viral culture of that milk sample was negative. 11 In our study, although SARS-CoV-2 RNA was detected in the throat swabs of some of the breastfed infants whose mothers' milk samples were positive for SARS-CoV-2 RNA (cases 11, 12 and 13), these findings do not show that the presence of SARS-CoV-2 RNA indicates viability of the virus and that human milk may be a source of infection for the infants. Moreover, since infants were not separated from mothers immediately after SARS-CoV-2 RNA was detected in the throat swab samples of the mothers, the possibility of mother-to-infants transmission of the virus via respiratory route or skin contact is high. We believe that the possibility of transmission of the virus from the mother to the infant through human milk is very low. IgM and IgG antibodies for SARS-CoV-2 in the milk of mothers with COVID-19, suggesting the possible protective effect of breastfeeding for infants by providing immune protection. 18 Limitations of our study include the small sample size that viral culture was not performed for human milk samples in which SARS-CoV-2 RNA was detected, and that additional examination of maternal and infant samples was not conducted. To our knowledge, this case series reports the largest cases with SARS-CoV-2 RNA positivity in human milk samples of mothers with COVID-19, thus far and suggests that SARS-CoV-2 can be excreted into human milk. However, these findings do not show that the presence of SARS-CoV-2 RNA indicates viability of the virus and that human milk may be a source of infection for infants. Additionally, based in part on the results of the present case series, we believe that the benefits of breastfeeding may outweigh the risk of SARS-CoV-2 infection in infants. Therefore, in line with the guidelines of the WHO and the CDC, we recommend that mothers with SARS-CoV-2 breastfeed their infants, provided that they wear a surgical mask. Further studies are needed to determine whether SARS-CoV-2 is shed into human milk and whether it can be transmitted to infants through the milk. We would like to thank Yusuf Yakupogulları (MD, Prof.) and Barıs Otlu (PhD., Prof.) from the microbiology department and Hilal Ermis (MD, Prof.) from Department of Pulnonary Medicine. Also, we thank all the medical staff members involved in treating those women and their infants. The authors have no conflict of interest to declare. This work has not been supported by grant from any funding agency in the public, commercial or not-for-profit sectors. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available because of privacy or ethical restrictions. Talat Kilic https://orcid.org/0000-0001-8125-9062 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Outbreak of Novel Coronavirus (SARS-CoV-2): first evidences from international scientific literature and pending questions Clinical management of COVID-19: living guidance. World Health Organization. Living guidance Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore SARS and pregnancy: a case report Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review Detection of SARS-CoV-2 in human breastmilk Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding Clinical characteristics of pregnant women with Covid-19 in Wuhan, China Virolactia in an asymptomatic mother with COVID-19 Evaluation for SARS-CoV-2 in breast milk from 18 infected women Excretion of SARS-CoV-2 in human breast milk Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient Mother-to-child transmission of herpes simplex virus HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn Antibodies in infants born to mothers with COVID-19 pneumonia Analysis of SARS-CoV-2 vertical transmission during pregnancy Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa Possibility of SARS-CoV-2 transmission from the breast milk of COVID-19 affected women patients to their infants: worries and strategies to counter it Breastfeeding provides passive and likely longlasting active immunity Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection Pregnancy & Breastfeeding. 2020 Clinical course of coronavirus disease-2019 in pregnancy A narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19